SEC Form 4 · accession 0001493152-26-042470
Hepion Pharmaceuticals, Inc. · HEPA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Vincent S LoPriore
Officer — Executive Chairman · Director
Period of report
Sep 3, 2026
Accepted (ET)
Sep 14, 2026 · 6:30 am EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001583771
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| WarrantsF2,F1 | $0.06 | Sep 3, 2026 | P | 12,500,000 | A | Sep 3, 2026 | Sep 3, 2031 | Common Stock | 12,500,000 | 22,500,000 | I |
Explanation of responses
- F1Warrant is only exercisable upon stockholder approval of an increase in the authorized shares of the Company's Common Stock.
- F2Mr. LoPriore is the Managing Member of Gravitas Capital LP and in such capacity has the right to vote and dispose of the securities held by such entity.